Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction

MLA

Mark C. Petrie, et al. Efficacy of an Implantable Cardioverter-Defibrillator in Patients with Diabetes and Heart Failure and Reduced Ejection Fraction. Aug. 2019. EBSCOhost, https://doi.org/10.1007/s00392-019-01415-z.

APA

Mark C. Petrie, Rasmus Rørth, Lars Køber, Pooja Dewan, John J.V. McMurray, Pardeep S. Jhund, & Søren Lund Kristensen. (2019). Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction. https://doi.org/10.1007/s00392-019-01415-z

Chicago

Mark C. Petrie, Rasmus Rørth, Lars Køber, Pooja Dewan, John J.V. McMurray, Pardeep S. Jhund, and Søren Lund Kristensen. 2019. “Efficacy of an Implantable Cardioverter-Defibrillator in Patients with Diabetes and Heart Failure and Reduced Ejection Fraction,” August. doi:10.1007/s00392-019-01415-z.